German Industry's 'State Of The Nation' Urges Higher Profile For Medtech In 2018
Other than regulatory concerns, 2017 was a relatively problem-free year for Germany's medtech industry. But that is not expected to last far into 2018, according to the industry group BVMed, which this week laid out its priorities for the year ahead. It seems likely that a new government comprising the same coalition partners as in the previous administration will be decided early in the new year, and with it will come new health-care policy aims and budgets for 2017-2021.
You may also be interested in...
Germany has joined the unfortunate group of global economies coupled with the tag "political uncertainty." That much was assured when the government coalition talks in Berlin collapsed last week. Below the surface, life and business goes on as usual – and medtech is no different – but the vacuum can only last for so long.
Germany's CDU leader Angela Merkel secured her fourth term as chancellor, but chastened by an election result that saw many of her 2013 voters turn to the liberals and far right, her hand is weakened. Indeed, the EU's rock of political stability has sprung many a surprise in delivering a 2017 election result that will give businesses a sense both of unease and promise, with the re-emergence of the liberal and business-focused FDP.
The passage of new hospital hygiene regulations by the German upper house earlier this month is likely to increase device sterilisation standards, enhance business for original equipment manufacturers and boost the standing of the diagnostics industry. Better hygiene disease prevention measures have long been advocated by the IVDs lobby group, the VDGH.